FindMyRecallSubscribe
Class III: unlikely to cause harmCompleted

Taro Pharmaceuticals U.S.A. Hydrocortisone 1% & Acetic Acid 2% Otic Recall

Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro P…

Taro Pharmaceuticals U.S.A., Inc. · Hawthorne, NY

Risk level
Class III
Reported by FDA
Aug 21, 2024
Recall ID
D-0633-2024
Check your lot numberHow we source this data

Summary

Taro Pharmaceuticals U.S.A. recalled Hydrocortisone 1% & Acetic Acid 2% Otic starting Aug 7, 2024. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0633-2024 on Aug 21, 2024. Reason: Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing. Status: Completed.

Why it was recalled

Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.

Product description

Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-3007-01

Lot numbers, UPCs & expiration codes

Lot # AD12890, Exp 09/30/2024

Where it was sold

Product was distributed to one distributor

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0633-2024
Classification
Class III
Status
Completed
Recall initiated
Aug 7, 2024
FDA report date
Aug 21, 2024
Quantity
96 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.

Original FDA data

Every field from FDA enforcement report D-0633-2024, exactly as published.

Show all FDA fields
City
Hawthorne
State
NY
Status
Completed
Country
United States
Event ID
95125
Address
3 Skyline Dr
Code information
Lot # AD12890, Exp 09/30/2024
Postal code
10532-2174
Report date
Aug 21, 2024
Product type
Drugs
Recall number
D-0633-2024
Classification
Class III
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
Product quantity
96 vials
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-3007-01
Distribution pattern
Product was distributed to one distributor
Recall initiation date
Aug 7, 2024
Initial firm notification
Letter
Center classification date
Aug 13, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0633-2024, published Aug 21, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls